Cytogenetics in multiple myeloma patients progressing into extramedullary disease
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F16%3AA1701J66" target="_blank" >RIV/61988987:17110/16:A1701J66 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216224:14110/16:00089123 RIV/65269705:_____/16:00065515 RIV/00843989:_____/16:E0105516
Výsledek na webu
—
DOI - Digital Object Identifier
—
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Cytogenetics in multiple myeloma patients progressing into extramedullary disease
Popis výsledku v původním jazyce
Background: Extramedullary disease in multiple myeloma patients is an uncommon event occurring either at the time of diagnosis, or during disease progression/relapse. This manifestation is frequently associated with poor outcome and resistance to treatment. We evaluated chromosomal alterations of plasma cells of multiple myeloma patients with extramedullary relapse, either in the bone marrow (BM) or at extramedullary sites, and in previous BM collection by interphase fluorescence in situ hybridization. Material and methods: Thirty-one patients [25 BM plasma cells (BMPCs), 18 extramedullary tumor plasma cells], of which 12 had paired samples of BM and extramedullary plasma cells and 14 had previous collection of BM, were investigated for the presence of chromosomal aberrations (CHAs): del(17)(p13), del (13)(q14), 14q32 disruption, t(4; 14)(p16; q32), t(14; 16)(q32; q23), gain(1)(q21), and hyperdiploidy status. Results: Overall, in unrelated samples, t(4; 14) was more prevalent in extramedullary plasma cells, and hyperdiploidy was more frequent in BMPCs. In paired samples, there was a higher frequency of del(13) (q14) and 14q32 disruption in BMPCs. Frequency of all studied CHAs was higher in BMPCs of extramedullary patients than in their previous sample collection. Conclusion: These data show that plasma cells harbor more aberrations during their transformation into extramedullary form.
Název v anglickém jazyce
Cytogenetics in multiple myeloma patients progressing into extramedullary disease
Popis výsledku anglicky
Background: Extramedullary disease in multiple myeloma patients is an uncommon event occurring either at the time of diagnosis, or during disease progression/relapse. This manifestation is frequently associated with poor outcome and resistance to treatment. We evaluated chromosomal alterations of plasma cells of multiple myeloma patients with extramedullary relapse, either in the bone marrow (BM) or at extramedullary sites, and in previous BM collection by interphase fluorescence in situ hybridization. Material and methods: Thirty-one patients [25 BM plasma cells (BMPCs), 18 extramedullary tumor plasma cells], of which 12 had paired samples of BM and extramedullary plasma cells and 14 had previous collection of BM, were investigated for the presence of chromosomal aberrations (CHAs): del(17)(p13), del (13)(q14), 14q32 disruption, t(4; 14)(p16; q32), t(14; 16)(q32; q23), gain(1)(q21), and hyperdiploidy status. Results: Overall, in unrelated samples, t(4; 14) was more prevalent in extramedullary plasma cells, and hyperdiploidy was more frequent in BMPCs. In paired samples, there was a higher frequency of del(13) (q14) and 14q32 disruption in BMPCs. Frequency of all studied CHAs was higher in BMPCs of extramedullary patients than in their previous sample collection. Conclusion: These data show that plasma cells harbor more aberrations during their transformation into extramedullary form.
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FD - Onkologie a hematologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.
Návaznosti
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2016
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
EUR J HAEMATOL
ISSN
0902-4441
e-ISSN
—
Svazek periodika
97
Číslo periodika v rámci svazku
1
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
8
Strana od-do
93-100
Kód UT WoS článku
000378432900015
EID výsledku v databázi Scopus
—